marketcaparena
Search

    ITGR

    Integer Holdings Corp

    Company overview

    Market capitalization
    $4.30B
    Employees
    11,000
    Latest publication
    2026-09-29
    About Integer Holdings Corp

    Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue464,110,000USD439,580,000USD470,895,000USD466,573,000USD472,831,000USD436,167,000USD449,497,000USD431,417,000USD
    Cost Of Revenue351,168,000USD329,985,000USD364,799,000USD358,284,000USD365,542,000USD330,239,000USD332,701,000USD313,980,000USD
    Gross Profit112,942,000USD109,595,000USD106,096,000USD108,289,000USD107,289,000USD105,928,000USD116,796,000USD117,437,000USD
    Selling General Administrative57,699,000USD45,018,000USD97,416,000USD36,479,000USD39,301,000USD38,889,000USD33,854,000USD33,854,000USD
    Total Operating Expenses78,414,000USD74,436,000USD54,982,000USD54,691,000USD54,586,000USD54,253,000USD59,764,000USD59,426,000USD
    Operating Income34,528,000USD35,159,000USD51,114,000USD53,598,000USD52,703,000USD51,675,000USD57,032,000USD58,011,000USD
    Total Other Income Expense Net-11,237,000USD-14,808,000USD-4,307,000USD-7,606,000USD-7,107,000USD-64,674,000USD-17,774,000USD-14,587,000USD
    Interest Expense10,135,000USD9,734,000USD9,254,000USD9,367,000USD9,624,000USD14,068,000USD12,139,000USD14,577,000USD
    Income Before Tax23,291,000USD20,351,000USD46,807,000USD45,992,000USD45,596,000USD-12,999,000USD39,258,000USD43,424,000USD
    Income Tax Expense-314,000USD3,845,000USD-1,801,000USD6,314,000USD8,587,000USD9,466,000USD6,285,000USD7,142,000USD
    Discontinued Operations0USD———————
    Net Income23,605,000USD16,506,000USD48,608,000USD39,678,000USD37,009,000USD-22,533,000USD32,703,000USD35,439,000USD
    Research Development—16,242,999USD10,109,000USD10,949,000USD14,240,000USD14,201,000USD10,614,000USD11,923,000USD
    Unclassified Operating Expenses—13,175,001USD-52,543,000USD7,263,000USD1,045,000USD1,163,000USD1,682,000USD3,014,000USD
    Net Interest Income—-10,565,000USD-5,501,000USD-10,508,000USD-10,537,000USD-14,900,000USD-10,640,000USD-15,482,000USD
    Tax Provision—3,845,000USD-1,801,000USD6,314,000USD8,587,000USD9,466,000USD6,285,000USD7,142,000USD
    Net Income From Continuing Ops—16,506,000USD48,608,000USD39,678,000USD37,009,000USD-22,465,000USD32,973,000USD36,282,000USD
    Ebit—30,085,000USD56,061,000USD55,359,000USD55,220,000USD1,069,000USD58,853,000USD60,944,000USD
    Ebitda—65,096,000USD91,570,000USD88,399,000USD87,506,000USD30,901,000USD86,457,000USD89,638,000USD
    Depreciation And Amortization—35,011,000USD35,509,000USD33,040,000USD32,286,000USD29,832,000USD27,604,000USD28,694,000USD
    Reconciled Depreciation—35,011,000USD35,509,000USD33,040,000USD32,286,000USD29,832,000USD28,927,000USD28,694,000USD
    Selling And Marketing Expenses——————13,614,000USD10,635,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue1,846,466,000USD1,716,596,000USD1,221,079,000USD1,258,094,000USD1,136,080,000USD1,075,502,000USD687,787,000USD663,945,000USD
    Cost Of Revenue1,420,655,000USD1,255,412,000USD884,109,000USD903,084,000USD782,070,000USD737,823,000USD456,129,000USD444,632,000USD
    Gross Profit425,811,000USD461,184,000USD336,970,000USD355,010,000USD354,010,000USD337,679,000USD231,658,000USD219,313,000USD
    Research Development46,347,000USD53,425,000USD51,985,000USD46,529,000USD48,850,000USD47,899,000USD58,974,000USD62,652,000USD
    Selling General Administrative211,748,000USD185,202,000USD141,418,000USD138,695,000USD120,402,000USD116,854,000USD83,593,000USD82,300,000USD
    Unclassified Operating Expenses-41,550,000USD14,319,000USD7,856,000USD12,151,000USD59,109,000USD80,003,000USD13,437,000USD13,022,000USD
    Total Operating Expenses216,545,000USD252,946,000USD201,259,000USD197,375,000USD228,361,000USD244,756,000USD156,004,000USD157,974,000USD
    Operating Income209,266,000USD208,238,000USD135,711,000USD157,635,000USD125,649,000USD92,923,000USD75,654,000USD61,339,000USD
    Interest Expense42,313,000USD56,374,000USD31,628,000USD52,545,000USD63,972,000USD68,331,000USD4,252,000USD11,261,000USD
    Net Interest Income-42,313,000USD-56,374,000USD-31,628,000USD-52,545,000USD-106,460,000USD-111,270,000USD——
    Income Before Tax125,396,000USD147,563,000USD101,063,000USD105,193,000USD49,259,000USD28,165,000USD76,579,000USD48,838,000USD
    Income Tax Expense22,566,000USD26,510,000USD8,042,999USD13,975,000USD-37,828,000USD3,287,000USD21,121,000USD12,571,000USD
    Tax Provision22,566,000USD26,510,000USD8,043,000USD13,975,000USD-44,852,000USD-4,776,000USD——
    Net Income102,762,000USD119,896,000USD96,808,000USD96,336,000USD66,679,000USD5,961,000USD55,458,000USD36,267,000USD
    Net Income From Continuing Ops102,830,000USD121,053,000USD93,020,000USD91,218,000USD66,755,000USD5,382,000USD55,084,000USD36,539,000USD
    Ebit167,709,000USD223,234,000USD143,059,000USD169,599,000USD162,713,000USD155,401,000USD93,420,000USD76,269,000USD
    Ebitda293,659,000USD332,942,000USD224,651,000USD247,494,000USD243,896,000USD228,269,000USD130,616,999USD112,235,000USD
    Depreciation And Amortization125,950,000USD109,708,000USD81,592,000USD77,895,000USD81,183,000USD72,868,000USD37,196,999USD35,966,000USD
    Reconciled Depreciation130,667,000USD111,031,000USD81,369,000USD77,895,000USD102,796,000USD———
    Total Other Income Expense Net-83,870,000USD-60,675,000USD-34,648,000USD-52,442,000USD-76,390,000USD-64,758,000USD925,000USD-12,501,000USD
    Non Operating Income Net Other——123,000USD578,000USD-9,587,000USD5,018,000USD807,000USD-546,000USD
    Discontinued Operations——3,788,000USD5,118,000USD-20,408,000USD-18,917,000USD——
    Net Income Applicable To Common Shares——96,808,000USD96,336,000USD66,679,000USD5,961,000USD55,458,000USD36,267,000USD
    Interest Income———55,520,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-07-03 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets3,423,597,000USD3,411,719,000USD3,410,577,000USD3,397,310,000USD3,370,935,000USD3,297,703,000USD3,077,971,000USD3,167,649,000USD
    Cash And Equivalents21,375,000USD———————
    Total Current Assets810,635,000USD774,764,000USD770,097,000USD778,122,000USD737,430,000USD702,203,000USD671,119,000USD730,032,000USD
    Other Current Assets43,449,000USD154,398,000USD153,118,000USD38,369,000USD42,372,000USD31,224,000USD28,409,000USD79,832,000USD
    Other Non Current Assets39,113,000USD———————
    Total Liabilities1,704,848,000USD———————
    Total Current Liabilities217,141,000USD206,344,000USD232,041,000USD209,821,000USD216,030,000USD206,403,000USD227,173,000USD222,398,000USD
    Other Current Liabilities97,082,000USD———————
    Other Non Current Liabilities16,638,000USD———————
    Total Stockholder Equity1,718,749,000USD1,696,892,000USD1,746,643,000USD1,745,837,000USD1,703,537,000USD1,606,704,000USD1,619,215,000USD1,621,186,000USD
    Total Equity Including Noncontrolling Interest1,718,749,000USD———————
    Long Term Debt1,237,883,000USD1,251,527,000USD1,185,179,000USD1,193,826,000USD1,202,495,000USD1,235,204,000USD980,153,000USD1,074,339,000USD
    Net Receivables338,729,000USD327,776,000USD346,079,000USD417,271,000USD405,486,000USD379,165,000USD349,041,000USD349,211,000USD
    Inventory288,058,000USD284,475,000USD253,739,000USD263,538,000USD266,437,000USD260,103,000USD247,126,000USD265,415,000USD
    Property Plant Equipment Net614,914,000USD675,313,000USD671,973,000USD648,668,000USD644,413,000USD625,038,000USD579,569,000USD568,144,000USD
    Goodwill1,104,651,000USD———————
    Intangible Assets788,841,000USD806,335,000USD825,435,000USD837,698,000USD854,545,000USD856,208,000USD778,286,000USD805,174,000USD
    Accounts Payable111,850,000USD115,001,000USD113,130,000USD110,744,000USD117,367,000USD112,023,000USD101,498,000USD116,837,000USD
    Short Term Debt8,209,000USD8,111,000USD22,105,000USD9,125,000USD8,922,000USD8,719,000USD25,661,000USD13,883,000USD
    Common Stock35,000USD35,000USD35,000USD35,000USD35,000USD35,000USD34,000USD34,000USD
    Retained Earnings1,034,166,000USD1,010,561,000USD994,055,000USD945,447,000USD905,769,000USD868,760,000USD891,247,000USD858,544,000USD
    Accumulated Other Comprehensive Income38,737,000USD44,657,000USD58,202,000USD61,647,000USD63,850,000USD10,746,000USD-14,043,000USD26,483,000USD
    Total Liab—1,714,827,000USD1,663,934,000USD1,651,473,000USD1,667,398,000USD1,690,999,000USD1,458,756,000USD1,546,463,000USD
    Other Current Liab—77,849,000USD91,593,000USD85,530,000USD86,967,000USD85,661,000USD92,596,000USD86,117,000USD
    Capital Stock—35,000USD35,000USD35,000USD35,000USD35,000USD34,000USD34,000USD
    Good Will—1,106,767,000USD1,110,908,000USD1,098,818,000USD1,100,371,000USD1,082,385,000USD1,017,729,000USD1,033,078,000USD
    Cash—8,115,000USD17,161,000USD58,944,000USD23,135,000USD31,711,000USD46,543,000USD35,574,000USD
    Cash And Short Term Investments—8,115,000USD17,161,000USD58,944,000USD23,135,000USD31,711,000USD46,543,000USD35,574,000USD
    Current Deferred Revenue—5,383,000USD5,213,000USD4,422,000USD2,774,000USD3,585,000USD4,440,000USD4,990,000USD
    Net Debt—1,373,344,000USD1,382,499,000USD1,252,210,000USD1,297,975,000USD1,322,898,000USD1,056,985,000USD1,135,759,000USD
    Short Long Term Debt Total—1,381,459,000USD1,399,660,000USD1,311,154,000USD1,321,110,000USD1,354,609,000USD1,103,528,000USD1,171,333,000USD
    Property Plant Equipment Gross—675,313,000USD1,241,010,000USD648,668,000USD644,413,000USD625,038,000USD1,081,750,000USD568,144,000USD
    Common Stock Shares Outstanding—34,433,000shares35,144,000shares35,608,000shares35,713,000shares33,916,000shares36,243,000shares35,791,000shares
    Non Current Assets Total—2,636,955,000USD2,640,480,000USD2,619,188,000USD2,633,505,000USD2,595,500,000USD2,406,852,000USD2,437,617,000USD
    Non Current Liabilities Total—1,508,483,000USD1,431,893,000USD1,441,652,000USD1,451,368,000USD1,484,596,000USD1,231,583,000USD1,324,065,000USD
    Non Current Liabilities Other—20,036,000USD19,910,000USD24,927,000USD24,445,000USD27,505,000USD25,360,000USD23,379,000USD
    Non Currrent Assets Other—19,331,000USD15,205,000USD25,459,000USD18,147,000USD23,499,000USD22,959,000USD14,206,000USD
    Net Working Capital—568,420,000USD538,056,000USD568,301,000USD521,400,000USD495,800,000USD443,946,000USD507,634,000USD
    Unclassified Non Current Assets—29,209,000USD——————
    Unclassified Non Current Liabilities—236,920,000USD226,804,000USD222,899,000USD224,428,000USD221,887,000USD226,070,000USD226,347,000USD
    Unclassified Equity—641,604,000USD694,316,000USD738,673,000USD733,848,000USD727,128,000USD741,943,000USD736,091,000USD
    Short Long Term Debt—————11,000USD10,000,000USD5,000,000USD
    Unclassified Current Liabilities—————-3,596,000USD-7,022,000USD-4,429,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets3,410,577,000USD3,077,971,000USD2,942,653,000USD2,794,386,000USD2,582,215,000USD2,371,857,000USD2,353,093,000USD2,326,681,000USD
    Intangible Assets825,435,000USD778,286,000USD783,146,000USD819,889,000USD807,810,000USD757,224,000USD775,784,000USD812,338,000USD
    Other Current Assets153,118,000USD28,409,000USD47,738,000USD27,005,000USD27,610,000USD15,896,000USD17,852,000USD15,104,000USD
    Total Liab1,663,934,000USD1,458,756,000USD1,423,611,000USD1,376,930,000USD1,227,518,000USD1,100,802,000USD1,200,605,000USD1,266,188,000USD
    Total Stockholder Equity1,746,643,000USD1,619,215,000USD1,519,042,000USD1,417,456,000USD1,354,697,000USD1,271,055,000USD1,152,488,000USD1,060,493,000USD
    Other Current Liab91,593,000USD92,596,000USD81,737,000USD66,790,000USD53,157,000USD54,345,000USD64,098,000USD54,976,000USD
    Common Stock35,000USD34,000USD33,000USD33,000USD33,000USD33,000USD33,000USD33,000USD
    Capital Stock35,000USD34,000USD33,000USD33,000USD33,000USD33,000USD33,000USD33,000USD
    Retained Earnings994,055,000USD891,247,000USD771,351,000USD680,701,000USD614,324,000USD517,516,000USD440,258,000USD344,498,000USD
    Good Will1,110,908,000USD1,017,729,000USD1,011,007,000USD982,192,000USD924,704,000USD859,442,000USD839,617,000USD832,338,000USD
    Cash17,161,000USD46,543,000USD23,674,000USD24,272,000USD17,885,000USD49,206,000USD13,535,000USD25,569,000USD
    Cash And Short Term Investments17,161,000USD46,543,000USD23,674,000USD24,272,000USD17,885,000USD49,206,000USD13,535,000USD25,569,000USD
    Total Current Assets770,097,000USD671,119,000USD617,668,000USD558,298,000USD452,982,000USD412,937,000USD415,395,000USD416,250,000USD
    Total Current Liabilities232,041,000USD227,173,000USD220,969,000USD223,752,000USD159,629,000USD156,191,000USD179,078,000USD164,570,000USD
    Current Deferred Revenue5,213,000USD4,440,000USD6,142,000USD5,616,000USD3,776,000USD2,498,000USD1,975,000USD4,782,000USD
    Net Debt1,382,499,000USD1,056,985,000USD1,029,067,000USD984,499,000USD887,928,000USD728,344,000USD845,858,000USD899,938,000USD
    Short Term Debt22,105,000USD25,661,000USD10,936,000USD29,643,000USD25,112,000USD45,931,000USD45,007,000USD37,500,000USD
    Short Long Term Debt Total1,399,660,000USD1,103,528,000USD1,052,741,000USD1,008,771,000USD905,813,000USD777,550,000USD859,393,000USD925,507,000USD
    Long Term Debt1,185,179,000USD980,153,000USD959,925,000USD907,073,000USD812,876,000USD693,758,000USD777,272,000USD888,007,000USD
    Net Receivables346,079,000USD349,041,000USD317,154,000USD298,255,000USD251,788,000USD198,512,000USD216,752,000USD185,501,000USD
    Inventory253,739,000USD247,126,000USD229,102,000USD208,766,000USD155,699,000USD149,323,000USD167,256,000USD190,076,000USD
    Accounts Payable113,130,000USD101,498,000USD118,258,000USD110,780,000USD76,859,000USD51,570,000USD64,975,000USD57,187,000USD
    Property Plant Equipment Net671,973,000USD579,569,000USD501,414,000USD400,904,000USD347,152,000USD299,117,000USD288,564,000USD231,269,000USD
    Property Plant Equipment Gross1,241,010,000USD1,081,750,000USD980,104,000USD400,904,000USD347,152,000USD299,117,000USD288,564,000USD231,269,000USD
    Accumulated Other Comprehensive Income58,202,000USD-14,043,000USD20,223,000USD5,329,000USD27,190,000USD52,692,000USD19,988,000USD33,004,000USD
    Common Stock Shares Outstanding35,594,000shares35,649,000shares33,758,000shares33,357,000shares33,258,000shares33,113,000shares33,037,000shares32,596,000shares
    Non Current Assets Total2,640,480,000USD2,406,852,000USD2,324,985,000USD2,236,088,000USD2,129,233,000USD1,958,920,000USD1,937,698,000USD1,910,431,000USD
    Non Current Liabilities Total1,431,893,000USD1,231,583,000USD1,202,642,000USD1,153,178,000USD1,067,889,000USD944,611,000USD1,021,527,000USD1,101,618,000USD
    Non Current Liabilities Other19,910,000USD25,360,000USD14,365,000USD21,385,000USD23,741,000USD68,549,000USD56,277,000USD9,701,000USD
    Non Currrent Assets Other15,205,000USD15,542,000USD10,589,000USD12,967,000USD22,027,000USD11,546,000USD7,036,000USD3,563,000USD
    Net Working Capital538,056,000USD443,946,000USD396,699,000USD334,546,000USD293,353,000USD256,746,000USD236,317,000USD251,680,000USD
    Unclassified Non Current Liabilities226,804,000USD226,070,000USD228,352,000USD51,932,000USD-135,479,000USD-212,992,000USD-204,332,000USD-213,611,000USD
    Unclassified Equity694,316,000USD741,943,000USD727,402,000USD731,360,000USD713,117,000USD700,781,000USD700,985,000USD691,050,000USD
    Short Long Term Debt—10,000,000USD—18,188,000USD15,250,000USD37,500,000USD37,500,000USD37,500,000USD
    Unclassified Current Liabilities—-7,022,000USD3,896,000USD-7,265,000USD-14,525,000USD-35,653,000USD-34,477,000USD-27,375,000USD
    Other Assets——1USD17,392,000USD49,567,000USD88,290,000USD11,474,000USD7,500,000USD
    Other Liab———172,788,000USD195,246,000USD212,992,000USD204,332,000USD213,611,000USD
    Net Tangible Assets———1,417,456,000USD-377,817,000USD-345,611,000USD-462,913,000USD-584,183,000USD
    Deferred Long Term Liab————171,505,000USD182,304,000USD187,978,000USD203,910,000USD
    Unclassified Non Current Assets————-22,027,000USD-56,699,000USD——
    Long Term Investments——————22,259,000USD26,986,000USD
    Treasury Stock——————-8,809,000USD-8,125,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income16,506,000USD48,608,000USD39,678,000USD37,009,000USD-22,487,000USD32,703,000USD35,439,000USD31,246,000USD
    Depreciation35,011,000USD35,509,000USD33,040,000USD32,286,000USD29,832,000USD28,927,000USD28,694,000USD27,225,000USD
    Stock Based Compensation6,662,000USD5,757,000USD4,931,000USD5,656,000USD6,880,000USD6,038,000USD6,115,000USD5,766,000USD
    Other Non Cash Items6,261,000USD3,176,000USD1,455,000USD4,558,000USD53,365,000USD-49,723,000USD5,518,000USD3,875,000USD
    Change To Account Receivables15,270,000USD-40,760,000USD-9,685,000USD-22,201,000USD-17,013,000USD11,515,000USD-9,846,000USD-10,613,000USD
    Change To Inventory-32,386,000USD9,665,000USD2,268,000USD-6,814,000USD-7,695,000USD13,436,000USD-4,280,000USD-9,964,000USD
    Change In Working Capital-39,762,000USD-30,866,000USD-13,649,000USD-35,534,000USD-40,369,000USD59,396,000USD-4,266,000USD-20,877,000USD
    Total Cash From Operating Activities24,695,000USD55,415,000USD65,595,000USD43,862,000USD31,276,000USD63,231,000USD71,500,000USD47,235,000USD
    Capital Expenditures-23,958,000USD-27,477,000USD-19,336,000USD-19,001,000USD-25,218,000USD-19,090,000USD-26,265,000USD-31,180,000USD
    Free Cash Flow737,000USD27,938,000USD46,259,000USD24,861,000USD6,058,000USD44,141,000USD45,235,000USD16,055,000USD
    Investments-13,998,000USD—-20,268,000USD-17,827,000USD-197,167,000USD29,617,000USD-26,235,000USD-30,598,000USD
    Total Cashflows From Investing Activities-37,901,000USD-35,469,000USD-20,268,000USD-17,827,000USD-197,167,000USD29,617,000USD-26,235,000USD-30,598,000USD
    Net Borrowings62,971,000USD-11,772,000USD-11,573,000USD-35,429,000USD236,640,000USD-90,955,000USD-40,818,000USD—
    Total Cash From Financing Activities3,830,000USD-61,720,000USD-10,711,000USD-35,589,000USD151,578,000USD-82,304,000USD-43,143,000USD-24,526,000USD
    Sale Purchase Of Stock-50,000,000USD-50,014,000USD—-2,575,000USD-14,132,000USD-165,000USD-148,000USD-1,277,000USD
    Change In Cash-9,046,000USD-41,783,000USD35,809,000USD-8,576,000USD-14,832,000USD10,969,000USD1,437,000USD-8,019,000USD
    Begin Period Cash Flow17,161,000USD58,944,000USD23,135,000USD31,711,000USD46,543,000USD35,574,000USD34,137,000USD42,156,000USD
    End Period Cash Flow8,115,000USD17,161,000USD58,944,000USD23,135,000USD31,711,000USD46,543,000USD35,574,000USD34,137,000USD
    Other Cashflows From Investing Activities-23,903,000USD8,000USD-191,140,000USD92,000USD5,000USD48,698,000USD-220,000USD—
    Other Cashflows From Financing Activities-9,141,000USD66,000USD4,626,000USD2,415,000USD-70,930,000USD8,964,000USD-2,177,000USD-1,385,000USD
    Unclassified Investing Cash Flow23,958,000USD-8,000,000USD210,476,000USD18,909,000USD25,213,000USD-29,608,000USD26,485,000USD31,180,000USD
    Unclassified Operating Cash Flow—-6,769,000USD——4,055,000USD-14,110,000USD——
    Unclassified Financing Cash Flow——-3,764,000USD————-21,864,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income102,808,000USD119,896,000USD90,650,000USD66,377,000USD96,808,000USD77,258,000USD96,336,000USD167,964,000USD
    Depreciation130,667,000USD111,031,000USD98,841,000USD91,991,000USD81,369,000USD79,324,000USD77,895,000USD88,988,000USD
    Stock Based Compensation23,224,000USD24,767,000USD23,283,000USD21,023,000USD16,185,000USD9,163,000USD9,294,000USD10,470,000USD
    Other Non Cash Items62,554,000USD18,245,000USD29,226,000USD30,335,000USD20,319,000USD6,401,000USD32,249,000USD-151,330,000USD
    Change To Account Receivables-89,659,000USD-24,979,000USD-21,083,000USD-41,380,000USD-17,539,000USD38,153,000USD-6,976,000USD9,289,000USD
    Change To Inventory-2,576,000USD-18,079,000USD-30,178,000USD-56,721,000USD4,700,000USD18,441,000USD3,724,000USD-16,094,000USD
    Change In Working Capital-120,418,000USD-54,624,000USD-52,297,000USD-75,847,000USD-47,745,000USD16,161,000USD-40,131,000USD-9,919,000USD
    Total Cash From Operating Activities196,148,000USD205,205,000USD180,213,000USD116,381,000USD156,666,000USD181,341,000USD165,358,000USD167,299,000USD
    Capital Expenditures-91,032,000USD-105,357,000USD-119,938,000USD-74,728,000USD-53,463,000USD-51,439,000USD-48,198,000USD-44,908,000USD
    Free Cash Flow105,116,000USD99,848,000USD60,275,000USD41,653,000USD103,203,000USD129,902,000USD117,160,000USD122,391,000USD
    Total Cashflows From Investing Activities-270,731,000USD-195,414,000USD-163,367,000USD-200,421,000USD-270,998,000USD-56,576,000USD-58,862,000USD536,670,000USD
    Net Borrowings177,866,000USD16,271,000USD27,432,000USD95,751,000USD95,595,000USD-88,015,000USD-117,885,000USD-732,460,000USD
    Total Cash From Financing Activities43,558,000USD13,321,000USD-18,014,000USD92,476,000USD81,986,000USD-88,578,000USD-117,926,000USD-725,080,000USD
    Sale Purchase Of Stock-50,014,000USD-10,938,000USD-3,098,000USD-2,929,000USD-4,592,000USD-3,820,000USD-3,283,000USD-5,029,000USD
    Change In Cash-29,382,000USD22,869,000USD-598,000USD6,387,000USD-31,321,000USD35,671,000USD-12,034,000USD-18,527,000USD
    Begin Period Cash Flow46,543,000USD23,674,000USD24,272,000USD17,885,000USD49,206,000USD13,535,000USD25,569,000USD44,096,000USD
    End Period Cash Flow17,161,000USD46,543,000USD23,674,000USD24,272,000USD17,885,000USD49,206,000USD13,535,000USD25,569,000USD
    Other Cashflows From Investing Activities-827,000USD48,487,000USD173,000USD639,000USD443,000USD82,000USD4,762,000USD1,379,000USD
    Other Cashflows From Financing Activities-86,552,000USD-3,692,000USD-42,538,000USD497,000USD-9,017,000USD2,748,000USD3,242,000USD-37,020,000USD
    Unclassified Operating Cash Flow-2,687,000USD-14,110,000USD-9,490,000USD-17,498,000USD-10,270,000USD-6,966,000USD-10,285,000USD61,126,000USD
    Unclassified Investing Cash Flow-178,872,000USD56,870,000USD70,506,000USD-126,636,000USD53,020,000USD51,357,000USD43,436,000USD43,529,000USD
    Unclassified Financing Cash Flow2,258,000USD11,680,000USD—2,086,000USD3,849,000USD1,066,000USD—49,429,000USD
    Investments—-195,414,000USD-114,108,000USD304,000USD-270,998,000USD-56,576,000USD-58,862,000USD536,670,000USD
    Change To Liabilities———29,033,000USD19,525,000USD-24,118,000USD-5,819,000USD-11,641,000USD
    Dividends Paid———-2,929,000USD-3,849,000USD-557,000USD-41,000USD—
    Cash And Cash Equivalents Changes———8,436,000USD-32,346,000USD36,187,000USD-11,430,000USD-18,527,000USD
    Exchange Rate Changes———————2,584,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-07-03ProductCardiac Rhythm Management Neuromodulation173,712,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03ProductCardio And Vascular280,308,000USDDisclosure
    Q2 2026Quarterly · 2026-07-03ProductOther Markets10,090,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCardiac Rhythm Management Neuromodulation168,264,000USD0001114483-26-000015
    Q1 2026Quarterly · 2026-03-31ProductCardio And Vascular261,733,000USD0001114483-26-000015
    Q1 2026Quarterly · 2026-03-31ProductOther Markets9,583,000USD0001114483-26-000015
    FY 2025Yearly · 2025-12-31GeographyCR173,524,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31GeographyIE99,160,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31GeographyPR131,261,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31GeographyRest of World469,885,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31GeographyUnited States979,807,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31ProductCardiac Rhythm Management Neuromodulation668,803,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31ProductCardio And Vascular1,107,084,000USD0001114483-26-000003
    FY 2025Yearly · 2025-12-31ProductOther Markets77,750,000USD0001114483-26-000003
    Q3 2025Quarterly · 2025-09-30ProductCardiac Rhythm Management Neuromodulation169,156,000USD0001114483-25-000134
    Q3 2025Quarterly · 2025-09-30ProductCardio And Vascular277,149,000USD0001114483-25-000134
    Q3 2025Quarterly · 2025-09-30ProductOther Markets21,386,000USD0001114483-25-000134
    Q2 2025Quarterly · 2025-06-30ProductCardiac Rhythm Management Neuromodulation171,998,000USD0001114483-25-000131
    Q2 2025Quarterly · 2025-06-30ProductCardio And Vascular286,855,000USD0001114483-25-000131
    Q2 2025Quarterly · 2025-06-30ProductOther Markets17,641,000USD0001114483-25-000131
    Q1 2025Quarterly · 2025-03-31ProductCardiac Rhythm Management Neuromodulation160,345,000USD0001114483-26-000015
    Q1 2025Quarterly · 2025-03-31ProductCardio And Vascular258,871,000USD0001114483-26-000015
    Q1 2025Quarterly · 2025-03-31ProductOther Markets18,176,000USD0001114483-26-000015
    FY 2024Yearly · 2024-12-31GeographyCR124,694,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31GeographyIE84,407,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31GeographyPR137,057,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31GeographyRest of World431,763,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31GeographyUnited States938,675,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31ProductCardiac Rhythm Management Neuromodulation660,610,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31ProductCardio And Vascular949,576,000USD0001114483-26-000003
    FY 2024Yearly · 2024-12-31ProductOther Markets106,410,000USD0001114483-26-000003
    Q3 2024Quarterly · 2024-09-30ProductCardiac Rhythm Management Neuromodulation165,094,000USD0001114483-25-000134
    Q3 2024Quarterly · 2024-09-30ProductCardio And Vascular241,009,000USD0001114483-25-000134
    Q3 2024Quarterly · 2024-09-30ProductOther Markets25,314,000USD0001114483-25-000134
    Q2 2024Quarterly · 2024-06-30ProductCardiac Rhythm Management Neuromodulation168,061,000USD0001114483-25-000131
    Q2 2024Quarterly · 2024-06-30ProductCardio And Vascular231,418,000USD0001114483-25-000131
    Q2 2024Quarterly · 2024-06-30ProductOther Markets28,407,000USD0001114483-25-000131
    Q2 2024Quarterly · 2024-06-30SegmentMedical427,378,000USD0001114483-24-000114
    Q2 2024Quarterly · 2024-06-30SegmentNon Medical8,824,000USD0001114483-24-000114
    Q1 2024Quarterly · 2024-03-31ProductCardiac Rhythm Management Neuromodulation156,931,000USD0001114483-25-000084
    Q1 2024Quarterly · 2024-03-31ProductCardio And Vascular221,851,000USD0001114483-25-000084
    Q1 2024Quarterly · 2024-03-31ProductOther Markets29,014,000USD0001114483-25-000084
    Q1 2024Quarterly · 2024-03-31SegmentMedical407,214,000USD0001114483-24-000059
    Q1 2024Quarterly · 2024-03-31SegmentNon Medical7,591,000USD0001114483-24-000059
    FY 2023Yearly · 2023-12-31GeographyCR108,421,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31GeographyIE69,092,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31GeographyPR121,487,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31GeographyRest of World383,730,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31GeographyUnited States872,926,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31ProductCardiac Rhythm Management Neuromodulation612,891,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31ProductCardio And Vascular836,343,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31ProductOther Markets106,422,000USD0001114483-26-000003
    FY 2023Yearly · 2023-12-31SegmentMedical1,553,340,000USD0001114483-24-000034
    FY 2023Yearly · 2023-12-31SegmentNon Medical43,333,000USD0001114483-24-000034
    Q3 2023Quarterly · 2023-09-30SegmentMedical395,902,000USD0001114483-23-000031
    Q3 2023Quarterly · 2023-09-30SegmentNon Medical8,791,000USD0001114483-23-000031
    Q2 2023Quarterly · 2023-06-30SegmentMedical389,111,000USD0001114483-24-000114
    Q2 2023Quarterly · 2023-06-30SegmentNon Medical10,933,000USD0001114483-24-000114
    Q1 2023Quarterly · 2023-03-31SegmentMedical364,266,000USD0001114483-24-000059
    Q1 2023Quarterly · 2023-03-31SegmentNon Medical14,519,000USD0001114483-24-000059
    FY 2022Yearly · 2022-12-31GeographyCR76,140,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31GeographyPR114,078,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31GeographyRest of World408,464,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31GeographyUnited States732,595,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31ProductCardiac Rhythm Management Neuromodulation534,371,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31ProductCardio And Vascular699,401,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31ProductOther Markets97,505,000USD0001114483-25-000034
    FY 2022Yearly · 2022-12-31SegmentMedical1,329,551,000USD0001114483-24-000034
    FY 2022Yearly · 2022-12-31SegmentNon Medical46,545,000USD0001114483-24-000034
    Q3 2022Quarterly · 2022-09-30SegmentMedical330,912,000USD0001114483-23-000031
    Q3 2022Quarterly · 2022-09-30SegmentNon Medical11,768,000USD0001114483-23-000031
    Q2 2022Quarterly · 2022-06-30SegmentMedical339,834,000USD0001114483-23-000024
    Q2 2022Quarterly · 2022-06-30SegmentNon Medical10,247,000USD0001114483-23-000024
    Q1 2022Quarterly · 2022-03-31SegmentMedical302,027,000USD0001114483-23-000016
    Q1 2022Quarterly · 2022-03-31SegmentNon Medical8,885,000USD0001114483-23-000016
    FY 2021Yearly · 2021-12-31GeographyCR66,975,000USD0001114483-24-000034
    FY 2021Yearly · 2021-12-31GeographyPR110,162,000USD0001114483-24-000034
    FY 2021Yearly · 2021-12-31GeographyRest of World372,440,000USD0001114483-24-000034
    FY 2021Yearly · 2021-12-31GeographyUnited States671,502,000USD0001114483-24-000034
    FY 2021Yearly · 2021-12-31SegmentMedical1,182,626,000USD0001114483-24-000034
    FY 2021Yearly · 2021-12-31SegmentNon Medical38,453,000USD0001114483-24-000034
    FY 2020Yearly · 2020-12-31GeographyCR58,853,000USD0001114483-23-000003
    FY 2020Yearly · 2020-12-31GeographyPR96,048,000USD0001114483-23-000003
    FY 2020Yearly · 2020-12-31GeographyRest of World321,737,000USD0001114483-23-000003
    FY 2020Yearly · 2020-12-31GeographyUnited States596,804,000USD0001114483-23-000003
    FY 2020Yearly · 2020-12-31SegmentMedical1,037,978,000USD0001114483-23-000003
    FY 2020Yearly · 2020-12-31SegmentNon Medical35,464,000USD0001114483-23-000003
    FY 2019Yearly · 2019-12-31GeographyCR63,634,000USD0001114483-22-000002
    FY 2019Yearly · 2019-12-31GeographyPR154,644,000USD0001114483-22-000002
    FY 2019Yearly · 2019-12-31GeographyRest of World341,342,000USD0001114483-22-000002
    FY 2019Yearly · 2019-12-31GeographyUnited States698,474,000USD0001114483-22-000002
    FY 2019Yearly · 2019-12-31SegmentMedical1,199,679,000USD0001114483-22-000002
    FY 2019Yearly · 2019-12-31SegmentNon Medical58,415,000USD0001114483-22-000002
    FY 2018Yearly · 2018-12-31GeographyCR62,044,000USD0001114483-21-000006
    FY 2018Yearly · 2018-12-31GeographyPR146,500,000USD0001114483-21-000006
    FY 2018Yearly · 2018-12-31GeographyRest of World319,209,000USD0001114483-21-000006
    FY 2018Yearly · 2018-12-31GeographyUnited States687,259,000USD0001114483-21-000006
    FY 2018Yearly · 2018-12-31SegmentMedical1,162,036,000USD0001114483-21-000006
    FY 2018Yearly · 2018-12-31SegmentNon Medical52,976,000USD0001114483-21-000006
    FY 2017Yearly · 2017-12-31SegmentMedical1,079,112,000USD0001114483-20-000003

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.